Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - GROSS PROFIT
Gross Profit RARE - Ultragenyx Pharmaceutical Inc.
484 M
LAST VALUE
20.14%
2 YEAR CAGR
38.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR